• NADH Reductive Stress in Leigh Syndrome

  2026-09-02

  This pilot study introduces streamlined LC-MS/MS quantification of NADH and NAD+ in patient-derived fibroblasts and an Ndufs4-knockout mouse model of Leigh syndrome. Elevated NADH, rather than a measurable reduction in NAD+, was associated with mitochondrial reductive stress, supporting NADH/NAD+ balance as a potentially more direct disease-severity marker than lactate alone.

• Irinotecan in Tumor–Stroma Assay Design

  2026-09-02

  Irinotecan and CPT-11 are most informative when tested in models that preserve tumor–stroma interactions. This guide connects SN-38 biology with patient-derived assembloid design, practical assay controls, and translational interpretation in colorectal cancer research.

• NADH Redox Strategy for Translational Research

  2026-09-01

  NADH is more than a metabolic reagent: it is a controllable lens on mitochondrial function, redox stress, and disease biology. This thought-leadership guide connects NADH and reduced nicotinamide adenine dinucleotide to diabetic nephropathy research, mitochondrial electron transport chain research, Leigh syndrome model development, and photocatalytic cancer therapy while outlining practical strategies for reproducible translational workflows.

• Solanesol B8776: Practical Assay Guide

  2026-09-01

  Solanesol B8776 provides a defined polyisoprenoid alcohol for hydrophobic biochemical, membrane-related, cell-based, and enzyme workflow development. It should be prepared in DMSO and handled as a fresh solution; it is unsuitable for water- or ethanol-based systems and is intended only for scientific research.

• FPS-ZM1: A Practical RAGE Inhibitor Workflow

  2026-08-31

  Use FPS-ZM1 to separate RAGE-dependent effects from broader metabolic or inflammatory responses in neuronal, amyloid beta, and barrier-focused assays. This workflow translates recent RAGE/POMC findings into controlled experiments without treating berberine biology and selective pharmacological inhibition as interchangeable.

• Recombinant Annexin V Purification for Biophysics

  2026-08-30

  Burger and colleagues developed a short purification strategy for recombinant human Annexin V that combined gentle bacterial-cell opening, calcium-dependent capture on liposomes, and final ion-exchange chromatography. The resulting protein was sufficiently pure for crystallography, electron microscopy, spectroscopy, and single-channel measurements, making the study an important methodological foundation for mechanistic Annexin V research.

• BI 2536: Separating Arrest from Cell Death

  2026-08-29

  BI 2536 is a selective PLK1 inhibitor for dissecting mitotic control, growth suppression, and apoptosis. This guide applies a two-dimensional assay framework to distinguish reduced proliferation from true cell killing in cancer research and tumor models.

• Protecting Liver Proteomes in Translational Research

  2026-08-29

  A thought-leadership guide to connecting single-cell discoveries in Mallory-Denk body pathogenesis with reliable protein workflows, highlighting how EDTA-free broad-spectrum protease inhibition can protect mechanistic interpretation without compromising divalent-cation-sensitive assays.

• BV6 IAP Antagonist: Mechanism and Research Use

  2026-08-28

  BV6 is a Smac mimetic and IAP antagonist that disrupts inhibitor of apoptosis protein signaling in cancer research. Product data report a 7.2 μM IC50 in H460 NSCLC cells, plus enhanced apoptosis, radiosensitivity, and experimental endometriosis control under defined preclinical conditions.

• AMG 9810: TRPV1 Antagonist Assay Guide

  2026-08-28

  AMG 9810 provides a selective way to separate TRPV1-driven calcium entry and CGRP secretion from broader metabolic-stress responses. This practical guide combines sensory-neuron workflows with a cautious AMPK–SQSTM1/NRF2 cross-domain framework for more interpretable pain mechanism research.

• In Vitro Cancer Drug Response: Viability vs Cell Death

  2026-08-27

  Hannah R. Schwartz’s dissertation examines a central problem in anticancer drug screening: relative viability and fractional viability are often treated as interchangeable even though they capture different biological outcomes. Its main contribution is a clearer framework for separating proliferative arrest from cell killing, improving interpretation of drug response magnitude and timing in vitro.

• MG-132 and Z-LLL-al: Proteasome Assay Guide

  2026-08-27

  MG-132, also known as Z-LLL-al, provides a practical way to perturb proteasome activity in apoptosis assay, cell-cycle, ROS, and cancer research workflows. This guide connects routine cell experiments with a reference model showing how proteasome inhibition can help distinguish RIPK3-dependent necroptosis from apoptosis and clarify immune consequences.

• Ridaforolimus: An mTOR Assay Strategy for Senescence

  2026-08-26

  Ridaforolimus, also called Deforolimus, provides a precise way to interrogate mTOR-dependent growth, translation, and angiogenesis. This guide connects its validated cancer-cell activity with machine-learning-enabled senolytic discovery while emphasizing assay controls that distinguish pathway inhibition from selective senescent-cell killing.

• Rapamycin in Adipose Stem Cell Stress Models

  2026-08-26

  Rapamycin (Sirolimus) provides a precise way to test whether mTOR signaling contributes to macrophage–adipose stem cell dysfunction, rather than treating obesity-associated ferroptosis as an isolated endpoint. This workflow combines pathway validation, mitochondrial phenotyping, and compartment-specific controls to distinguish mTOR-dependent effects from general cytotoxicity.

• Indazole/Indole Glucagon Receptor Antagonists

  2026-08-25

  Lin and colleagues reported a new indazole- and indole-based series of glucagon receptor antagonists derived from the pyrazole lead MK-0893. Structure–activity relationship studies produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity for GRA 16d in glucagon receptor humanized mouse models.

453 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page